nodes	percent_of_prediction	percent_of_DWPC	metapath
Phentermine—CYP1A2—Clobetasol propionate—psoriasis	0.213	0.307	CbGbCtD
Phentermine—CYP1A2—Methoxsalen—psoriasis	0.112	0.161	CbGbCtD
Phentermine—CYP2D6—Hydroxyurea—psoriasis	0.101	0.145	CbGbCtD
Phentermine—CYP2C9—Cholecalciferol—psoriasis	0.0667	0.0964	CbGbCtD
Phentermine—CYP2D6—Cholecalciferol—psoriasis	0.061	0.0881	CbGbCtD
Phentermine—CYP2C9—Cyclosporine—psoriasis	0.0439	0.0633	CbGbCtD
Phentermine—CYP2D6—Cyclosporine—psoriasis	0.0401	0.0579	CbGbCtD
Phentermine—CYP2C9—Dexamethasone—psoriasis	0.0289	0.0417	CbGbCtD
Phentermine—CYP2D6—Dexamethasone—psoriasis	0.0264	0.0381	CbGbCtD
Phentermine—Asthenia—Calcitriol—psoriasis	0.00103	0.00345	CcSEcCtD
Phentermine—Psychotic disorder—Betamethasone—psoriasis	0.00102	0.00343	CcSEcCtD
Phentermine—Psychotic disorder—Dexamethasone—psoriasis	0.00102	0.00343	CcSEcCtD
Phentermine—Acute coronary syndrome—Mycophenolate mofetil—psoriasis	0.00102	0.00343	CcSEcCtD
Phentermine—Myocardial infarction—Mycophenolate mofetil—psoriasis	0.00102	0.00341	CcSEcCtD
Phentermine—Rash—Methoxsalen—psoriasis	0.00101	0.0034	CcSEcCtD
Phentermine—Dermatitis—Methoxsalen—psoriasis	0.00101	0.0034	CcSEcCtD
Phentermine—Urticaria—Acitretin—psoriasis	0.00101	0.0034	CcSEcCtD
Phentermine—Tension—Mycophenolic acid—psoriasis	0.00101	0.00338	CcSEcCtD
Phentermine—Abdominal pain—Acitretin—psoriasis	0.00101	0.00338	CcSEcCtD
Phentermine—Headache—Methoxsalen—psoriasis	0.00101	0.00338	CcSEcCtD
Phentermine—Oedema—Hydroxyurea—psoriasis	0.001	0.00336	CcSEcCtD
Phentermine—Nervousness—Mycophenolic acid—psoriasis	0.000997	0.00335	CcSEcCtD
Phentermine—Cardiac arrest—Betamethasone—psoriasis	0.000995	0.00334	CcSEcCtD
Phentermine—Cardiac arrest—Dexamethasone—psoriasis	0.000995	0.00334	CcSEcCtD
Phentermine—Diarrhoea—Calcitriol—psoriasis	0.00098	0.00329	CcSEcCtD
Phentermine—Tremor—Mycophenolic acid—psoriasis	0.000962	0.00323	CcSEcCtD
Phentermine—Nausea—Methoxsalen—psoriasis	0.000954	0.0032	CcSEcCtD
Phentermine—Acute coronary syndrome—Prednisolone—psoriasis	0.000953	0.0032	CcSEcCtD
Phentermine—Myocardial infarction—Prednisolone—psoriasis	0.000948	0.00318	CcSEcCtD
Phentermine—Agitation—Mycophenolic acid—psoriasis	0.000943	0.00317	CcSEcCtD
Phentermine—Cardiac failure—Prednisone—psoriasis	0.000934	0.00314	CcSEcCtD
Phentermine—Acute coronary syndrome—Hydrocortisone—psoriasis	0.000931	0.00312	CcSEcCtD
Phentermine—Hallucination—Mycophenolate mofetil—psoriasis	0.000926	0.00311	CcSEcCtD
Phentermine—Myocardial infarction—Hydrocortisone—psoriasis	0.000926	0.00311	CcSEcCtD
Phentermine—Asthenia—Acitretin—psoriasis	0.000914	0.00307	CcSEcCtD
Phentermine—Vomiting—Calcitriol—psoriasis	0.00091	0.00306	CcSEcCtD
Phentermine—Palpitations—Mycophenolic acid—psoriasis	0.000907	0.00304	CcSEcCtD
Phentermine—Rash—Calcitriol—psoriasis	0.000903	0.00303	CcSEcCtD
Phentermine—Dermatitis—Calcitriol—psoriasis	0.000902	0.00303	CcSEcCtD
Phentermine—Headache—Calcitriol—psoriasis	0.000897	0.00301	CcSEcCtD
Phentermine—Psychotic disorder—Prednisone—psoriasis	0.00089	0.00299	CcSEcCtD
Phentermine—Hypertension—Mycophenolic acid—psoriasis	0.000886	0.00297	CcSEcCtD
Phentermine—Dyspepsia—Hydroxyurea—psoriasis	0.00088	0.00295	CcSEcCtD
Phentermine—Acute coronary syndrome—Triamcinolone—psoriasis	0.000877	0.00294	CcSEcCtD
Phentermine—Chest pain—Mycophenolic acid—psoriasis	0.000874	0.00293	CcSEcCtD
Phentermine—Diarrhoea—Acitretin—psoriasis	0.000872	0.00293	CcSEcCtD
Phentermine—Myocardial infarction—Triamcinolone—psoriasis	0.000872	0.00292	CcSEcCtD
Phentermine—Diarrhoea—Fluocinolone Acetonide—psoriasis	0.000869	0.00292	CcSEcCtD
Phentermine—Cardiac arrest—Prednisone—psoriasis	0.000867	0.00291	CcSEcCtD
Phentermine—Gastrointestinal disorder—Hydroxyurea—psoriasis	0.000863	0.0029	CcSEcCtD
Phentermine—Fatigue—Hydroxyurea—psoriasis	0.000862	0.00289	CcSEcCtD
Phentermine—Constipation—Hydroxyurea—psoriasis	0.000855	0.00287	CcSEcCtD
Phentermine—Dry mouth—Mycophenolic acid—psoriasis	0.000855	0.00287	CcSEcCtD
Phentermine—Nausea—Calcitriol—psoriasis	0.000851	0.00285	CcSEcCtD
Phentermine—Hallucination—Hydrocortisone—psoriasis	0.000843	0.00283	CcSEcCtD
Phentermine—Dizziness—Acitretin—psoriasis	0.000842	0.00283	CcSEcCtD
Phentermine—Dizziness—Fluocinolone Acetonide—psoriasis	0.00084	0.00282	CcSEcCtD
Phentermine—Oedema—Mycophenolic acid—psoriasis	0.000838	0.00281	CcSEcCtD
Phentermine—Tachycardia—Mycophenolic acid—psoriasis	0.000818	0.00274	CcSEcCtD
Phentermine—Tension—Cyclosporine—psoriasis	0.000815	0.00273	CcSEcCtD
Phentermine—Vomiting—Acitretin—psoriasis	0.00081	0.00272	CcSEcCtD
Phentermine—Vomiting—Fluocinolone Acetonide—psoriasis	0.000808	0.00271	CcSEcCtD
Phentermine—Nervousness—Cyclosporine—psoriasis	0.000806	0.00271	CcSEcCtD
Phentermine—Rash—Acitretin—psoriasis	0.000803	0.0027	CcSEcCtD
Phentermine—Dermatitis—Acitretin—psoriasis	0.000802	0.00269	CcSEcCtD
Phentermine—Rash—Fluocinolone Acetonide—psoriasis	0.000801	0.00269	CcSEcCtD
Phentermine—Dermatitis—Fluocinolone Acetonide—psoriasis	0.0008	0.00269	CcSEcCtD
Phentermine—Headache—Acitretin—psoriasis	0.000798	0.00268	CcSEcCtD
Phentermine—Headache—Fluocinolone Acetonide—psoriasis	0.000796	0.00267	CcSEcCtD
Phentermine—Acute coronary syndrome—Betamethasone—psoriasis	0.000795	0.00267	CcSEcCtD
Phentermine—Acute coronary syndrome—Dexamethasone—psoriasis	0.000795	0.00267	CcSEcCtD
Phentermine—Tension—Mycophenolate mofetil—psoriasis	0.000795	0.00267	CcSEcCtD
Phentermine—Myocardial infarction—Dexamethasone—psoriasis	0.000791	0.00265	CcSEcCtD
Phentermine—Myocardial infarction—Betamethasone—psoriasis	0.000791	0.00265	CcSEcCtD
Phentermine—Nervousness—Mycophenolate mofetil—psoriasis	0.000787	0.00264	CcSEcCtD
Phentermine—Tremor—Cyclosporine—psoriasis	0.000778	0.00261	CcSEcCtD
Phentermine—Cerebrovascular accident—Methotrexate—psoriasis	0.000778	0.00261	CcSEcCtD
Phentermine—Agitation—Cyclosporine—psoriasis	0.000763	0.00256	CcSEcCtD
Phentermine—Tremor—Mycophenolate mofetil—psoriasis	0.000759	0.00255	CcSEcCtD
Phentermine—Insomnia—Mycophenolic acid—psoriasis	0.000758	0.00254	CcSEcCtD
Phentermine—Nausea—Acitretin—psoriasis	0.000757	0.00254	CcSEcCtD
Phentermine—Nausea—Fluocinolone Acetonide—psoriasis	0.000755	0.00253	CcSEcCtD
Phentermine—Agitation—Mycophenolate mofetil—psoriasis	0.000744	0.0025	CcSEcCtD
Phentermine—Dyspepsia—Mycophenolic acid—psoriasis	0.000737	0.00247	CcSEcCtD
Phentermine—Erectile dysfunction—Prednisone—psoriasis	0.000726	0.00244	CcSEcCtD
Phentermine—Gastrointestinal disorder—Mycophenolic acid—psoriasis	0.000723	0.00243	CcSEcCtD
Phentermine—Fatigue—Mycophenolic acid—psoriasis	0.000722	0.00242	CcSEcCtD
Phentermine—Hallucination—Dexamethasone—psoriasis	0.000721	0.00242	CcSEcCtD
Phentermine—Hallucination—Betamethasone—psoriasis	0.000721	0.00242	CcSEcCtD
Phentermine—Asthenia—Hydroxyurea—psoriasis	0.000718	0.00241	CcSEcCtD
Phentermine—Hypertension—Cyclosporine—psoriasis	0.000717	0.00241	CcSEcCtD
Phentermine—Constipation—Mycophenolic acid—psoriasis	0.000716	0.0024	CcSEcCtD
Phentermine—Palpitations—Mycophenolate mofetil—psoriasis	0.000716	0.0024	CcSEcCtD
Phentermine—Chest pain—Cyclosporine—psoriasis	0.000707	0.00237	CcSEcCtD
Phentermine—Hypertension—Mycophenolate mofetil—psoriasis	0.000699	0.00235	CcSEcCtD
Phentermine—Acute coronary syndrome—Prednisone—psoriasis	0.000693	0.00232	CcSEcCtD
Phentermine—Dry mouth—Cyclosporine—psoriasis	0.000691	0.00232	CcSEcCtD
Phentermine—Chest pain—Mycophenolate mofetil—psoriasis	0.00069	0.00231	CcSEcCtD
Phentermine—Myocardial infarction—Prednisone—psoriasis	0.000689	0.00231	CcSEcCtD
Phentermine—Diarrhoea—Hydroxyurea—psoriasis	0.000684	0.0023	CcSEcCtD
Phentermine—Oedema—Cyclosporine—psoriasis	0.000678	0.00227	CcSEcCtD
Phentermine—Dry mouth—Mycophenolate mofetil—psoriasis	0.000674	0.00226	CcSEcCtD
Phentermine—Abdominal pain—Mycophenolic acid—psoriasis	0.000662	0.00222	CcSEcCtD
Phentermine—Dizziness—Hydroxyurea—psoriasis	0.000661	0.00222	CcSEcCtD
Phentermine—Oedema—Mycophenolate mofetil—psoriasis	0.000661	0.00222	CcSEcCtD
Phentermine—Hypertension—Prednisolone—psoriasis	0.000652	0.00219	CcSEcCtD
Phentermine—Tachycardia—Mycophenolate mofetil—psoriasis	0.000645	0.00217	CcSEcCtD
Phentermine—Hypertension—Hydrocortisone—psoriasis	0.000637	0.00214	CcSEcCtD
Phentermine—Vomiting—Hydroxyurea—psoriasis	0.000636	0.00213	CcSEcCtD
Phentermine—Rash—Hydroxyurea—psoriasis	0.000631	0.00212	CcSEcCtD
Phentermine—Dermatitis—Hydroxyurea—psoriasis	0.00063	0.00211	CcSEcCtD
Phentermine—Hallucination—Prednisone—psoriasis	0.000628	0.00211	CcSEcCtD
Phentermine—Headache—Hydroxyurea—psoriasis	0.000627	0.0021	CcSEcCtD
Phentermine—Oedema—Prednisolone—psoriasis	0.000617	0.00207	CcSEcCtD
Phentermine—Insomnia—Cyclosporine—psoriasis	0.000613	0.00206	CcSEcCtD
Phentermine—CYP2D6—CYP2E1 reactions—CYP2S1—psoriasis	0.000607	0.0641	CbGpPWpGaD
Phentermine—Erectile dysfunction—Methotrexate—psoriasis	0.000607	0.00204	CcSEcCtD
Phentermine—Oedema—Hydrocortisone—psoriasis	0.000602	0.00202	CcSEcCtD
Phentermine—Tachycardia—Prednisolone—psoriasis	0.000602	0.00202	CcSEcCtD
Phentermine—CYP2C9—CYP2E1 reactions—CYP2S1—psoriasis	0.000602	0.0636	CbGpPWpGaD
Phentermine—Asthenia—Mycophenolic acid—psoriasis	0.000601	0.00202	CcSEcCtD
Phentermine—Hypertension—Triamcinolone—psoriasis	0.0006	0.00201	CcSEcCtD
Phentermine—Insomnia—Mycophenolate mofetil—psoriasis	0.000598	0.00201	CcSEcCtD
Phentermine—Dyspepsia—Cyclosporine—psoriasis	0.000597	0.002	CcSEcCtD
Phentermine—Nausea—Hydroxyurea—psoriasis	0.000594	0.00199	CcSEcCtD
Phentermine—Tachycardia—Hydrocortisone—psoriasis	0.000588	0.00197	CcSEcCtD
Phentermine—Gastrointestinal disorder—Cyclosporine—psoriasis	0.000585	0.00196	CcSEcCtD
Phentermine—Fatigue—Cyclosporine—psoriasis	0.000584	0.00196	CcSEcCtD
Phentermine—Dyspepsia—Mycophenolate mofetil—psoriasis	0.000582	0.00195	CcSEcCtD
Phentermine—Constipation—Cyclosporine—psoriasis	0.00058	0.00194	CcSEcCtD
Phentermine—Dry mouth—Triamcinolone—psoriasis	0.000579	0.00194	CcSEcCtD
Phentermine—Diarrhoea—Mycophenolic acid—psoriasis	0.000573	0.00192	CcSEcCtD
Phentermine—Gastrointestinal disorder—Mycophenolate mofetil—psoriasis	0.000571	0.00192	CcSEcCtD
Phentermine—Oedema—Triamcinolone—psoriasis	0.000567	0.0019	CcSEcCtD
Phentermine—CYP2D6—Miscellaneous substrates—CYP2S1—psoriasis	0.000566	0.0598	CbGpPWpGaD
Phentermine—Constipation—Mycophenolate mofetil—psoriasis	0.000565	0.0019	CcSEcCtD
Phentermine—Insomnia—Prednisolone—psoriasis	0.000558	0.00187	CcSEcCtD
Phentermine—Dizziness—Mycophenolic acid—psoriasis	0.000554	0.00186	CcSEcCtD
Phentermine—Tachycardia—Triamcinolone—psoriasis	0.000553	0.00186	CcSEcCtD
Phentermine—Insomnia—Hydrocortisone—psoriasis	0.000545	0.00183	CcSEcCtD
Phentermine—Hypertension—Dexamethasone—psoriasis	0.000544	0.00183	CcSEcCtD
Phentermine—Hypertension—Betamethasone—psoriasis	0.000544	0.00183	CcSEcCtD
Phentermine—Urticaria—Cyclosporine—psoriasis	0.000538	0.00181	CcSEcCtD
Phentermine—Abdominal pain—Cyclosporine—psoriasis	0.000536	0.0018	CcSEcCtD
Phentermine—Vomiting—Mycophenolic acid—psoriasis	0.000533	0.00179	CcSEcCtD
Phentermine—Dyspepsia—Hydrocortisone—psoriasis	0.00053	0.00178	CcSEcCtD
Phentermine—Rash—Mycophenolic acid—psoriasis	0.000528	0.00177	CcSEcCtD
Phentermine—Dermatitis—Mycophenolic acid—psoriasis	0.000528	0.00177	CcSEcCtD
Phentermine—Urticaria—Mycophenolate mofetil—psoriasis	0.000525	0.00176	CcSEcCtD
Phentermine—Headache—Mycophenolic acid—psoriasis	0.000525	0.00176	CcSEcCtD
Phentermine—Abdominal pain—Mycophenolate mofetil—psoriasis	0.000523	0.00175	CcSEcCtD
Phentermine—Gastrointestinal disorder—Hydrocortisone—psoriasis	0.00052	0.00174	CcSEcCtD
Phentermine—Fatigue—Hydrocortisone—psoriasis	0.000519	0.00174	CcSEcCtD
Phentermine—Oedema—Betamethasone—psoriasis	0.000515	0.00173	CcSEcCtD
Phentermine—Oedema—Dexamethasone—psoriasis	0.000515	0.00173	CcSEcCtD
Phentermine—Insomnia—Triamcinolone—psoriasis	0.000513	0.00172	CcSEcCtD
Phentermine—Agitation—Prednisone—psoriasis	0.000505	0.00169	CcSEcCtD
Phentermine—Tachycardia—Dexamethasone—psoriasis	0.000502	0.00169	CcSEcCtD
Phentermine—Tachycardia—Betamethasone—psoriasis	0.000502	0.00169	CcSEcCtD
Phentermine—Dyspepsia—Triamcinolone—psoriasis	0.000499	0.00168	CcSEcCtD
Phentermine—Nausea—Mycophenolic acid—psoriasis	0.000498	0.00167	CcSEcCtD
Phentermine—Urticaria—Prednisolone—psoriasis	0.00049	0.00164	CcSEcCtD
Phentermine—Fatigue—Triamcinolone—psoriasis	0.000489	0.00164	CcSEcCtD
Phentermine—Asthenia—Cyclosporine—psoriasis	0.000486	0.00163	CcSEcCtD
Phentermine—Urticaria—Hydrocortisone—psoriasis	0.000478	0.00161	CcSEcCtD
Phentermine—Abdominal pain—Hydrocortisone—psoriasis	0.000476	0.0016	CcSEcCtD
Phentermine—Asthenia—Mycophenolate mofetil—psoriasis	0.000474	0.00159	CcSEcCtD
Phentermine—Hypertension—Prednisone—psoriasis	0.000474	0.00159	CcSEcCtD
Phentermine—Insomnia—Dexamethasone—psoriasis	0.000465	0.00156	CcSEcCtD
Phentermine—Insomnia—Betamethasone—psoriasis	0.000465	0.00156	CcSEcCtD
Phentermine—Diarrhoea—Cyclosporine—psoriasis	0.000464	0.00156	CcSEcCtD
Phentermine—MAOB—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000464	0.049	CbGpPWpGaD
Phentermine—Dyspepsia—Dexamethasone—psoriasis	0.000453	0.00152	CcSEcCtD
Phentermine—Dyspepsia—Betamethasone—psoriasis	0.000453	0.00152	CcSEcCtD
Phentermine—Diarrhoea—Mycophenolate mofetil—psoriasis	0.000452	0.00152	CcSEcCtD
Phentermine—Urticaria—Triamcinolone—psoriasis	0.000451	0.00151	CcSEcCtD
Phentermine—Dizziness—Cyclosporine—psoriasis	0.000448	0.0015	CcSEcCtD
Phentermine—Oedema—Prednisone—psoriasis	0.000448	0.0015	CcSEcCtD
Phentermine—Gastrointestinal disorder—Dexamethasone—psoriasis	0.000444	0.00149	CcSEcCtD
Phentermine—Gastrointestinal disorder—Betamethasone—psoriasis	0.000444	0.00149	CcSEcCtD
Phentermine—Fatigue—Betamethasone—psoriasis	0.000444	0.00149	CcSEcCtD
Phentermine—Fatigue—Dexamethasone—psoriasis	0.000444	0.00149	CcSEcCtD
Phentermine—Tachycardia—Prednisone—psoriasis	0.000437	0.00147	CcSEcCtD
Phentermine—Dizziness—Mycophenolate mofetil—psoriasis	0.000437	0.00147	CcSEcCtD
Phentermine—Asthenia—Hydrocortisone—psoriasis	0.000432	0.00145	CcSEcCtD
Phentermine—Vomiting—Cyclosporine—psoriasis	0.000431	0.00145	CcSEcCtD
Phentermine—Rash—Cyclosporine—psoriasis	0.000427	0.00143	CcSEcCtD
Phentermine—Dermatitis—Cyclosporine—psoriasis	0.000427	0.00143	CcSEcCtD
Phentermine—Headache—Cyclosporine—psoriasis	0.000425	0.00142	CcSEcCtD
Phentermine—Vomiting—Mycophenolate mofetil—psoriasis	0.00042	0.00141	CcSEcCtD
Phentermine—Rash—Mycophenolate mofetil—psoriasis	0.000417	0.0014	CcSEcCtD
Phentermine—Dermatitis—Mycophenolate mofetil—psoriasis	0.000416	0.0014	CcSEcCtD
Phentermine—Headache—Mycophenolate mofetil—psoriasis	0.000414	0.00139	CcSEcCtD
Phentermine—Diarrhoea—Hydrocortisone—psoriasis	0.000412	0.00138	CcSEcCtD
Phentermine—Urticaria—Dexamethasone—psoriasis	0.000409	0.00137	CcSEcCtD
Phentermine—Urticaria—Betamethasone—psoriasis	0.000409	0.00137	CcSEcCtD
Phentermine—Dizziness—Prednisolone—psoriasis	0.000408	0.00137	CcSEcCtD
Phentermine—Asthenia—Triamcinolone—psoriasis	0.000407	0.00137	CcSEcCtD
Phentermine—Abdominal pain—Betamethasone—psoriasis	0.000407	0.00137	CcSEcCtD
Phentermine—Abdominal pain—Dexamethasone—psoriasis	0.000407	0.00137	CcSEcCtD
Phentermine—Insomnia—Prednisone—psoriasis	0.000405	0.00136	CcSEcCtD
Phentermine—Nausea—Cyclosporine—psoriasis	0.000403	0.00135	CcSEcCtD
Phentermine—Dizziness—Hydrocortisone—psoriasis	0.000398	0.00134	CcSEcCtD
Phentermine—Dyspepsia—Prednisone—psoriasis	0.000394	0.00132	CcSEcCtD
Phentermine—Nausea—Mycophenolate mofetil—psoriasis	0.000393	0.00132	CcSEcCtD
Phentermine—Chest pain—Methotrexate—psoriasis	0.000391	0.00131	CcSEcCtD
Phentermine—Rash—Prednisolone—psoriasis	0.000389	0.0013	CcSEcCtD
Phentermine—Dermatitis—Prednisolone—psoriasis	0.000388	0.0013	CcSEcCtD
Phentermine—Fatigue—Prednisone—psoriasis	0.000386	0.0013	CcSEcCtD
Phentermine—Headache—Prednisolone—psoriasis	0.000386	0.0013	CcSEcCtD
Phentermine—Constipation—Prednisone—psoriasis	0.000383	0.00129	CcSEcCtD
Phentermine—Vomiting—Hydrocortisone—psoriasis	0.000383	0.00129	CcSEcCtD
Phentermine—Rash—Hydrocortisone—psoriasis	0.00038	0.00127	CcSEcCtD
Phentermine—Dermatitis—Hydrocortisone—psoriasis	0.000379	0.00127	CcSEcCtD
Phentermine—Headache—Hydrocortisone—psoriasis	0.000377	0.00127	CcSEcCtD
Phentermine—CYP2D6—Xenobiotics—CYP2S1—psoriasis	0.000376	0.0397	CbGpPWpGaD
Phentermine—Dizziness—Triamcinolone—psoriasis	0.000375	0.00126	CcSEcCtD
Phentermine—CYP2C9—Xenobiotics—CYP2S1—psoriasis	0.000373	0.0394	CbGpPWpGaD
Phentermine—Asthenia—Dexamethasone—psoriasis	0.000369	0.00124	CcSEcCtD
Phentermine—Asthenia—Betamethasone—psoriasis	0.000369	0.00124	CcSEcCtD
Phentermine—Nausea—Prednisolone—psoriasis	0.000366	0.00123	CcSEcCtD
Phentermine—Vomiting—Triamcinolone—psoriasis	0.000361	0.00121	CcSEcCtD
Phentermine—Nausea—Hydrocortisone—psoriasis	0.000358	0.0012	CcSEcCtD
Phentermine—Rash—Triamcinolone—psoriasis	0.000358	0.0012	CcSEcCtD
Phentermine—Dermatitis—Triamcinolone—psoriasis	0.000357	0.0012	CcSEcCtD
Phentermine—Urticaria—Prednisone—psoriasis	0.000356	0.00119	CcSEcCtD
Phentermine—Headache—Triamcinolone—psoriasis	0.000355	0.00119	CcSEcCtD
Phentermine—Abdominal pain—Prednisone—psoriasis	0.000354	0.00119	CcSEcCtD
Phentermine—Diarrhoea—Dexamethasone—psoriasis	0.000352	0.00118	CcSEcCtD
Phentermine—Diarrhoea—Betamethasone—psoriasis	0.000352	0.00118	CcSEcCtD
Phentermine—Dizziness—Dexamethasone—psoriasis	0.00034	0.00114	CcSEcCtD
Phentermine—Dizziness—Betamethasone—psoriasis	0.00034	0.00114	CcSEcCtD
Phentermine—Insomnia—Methotrexate—psoriasis	0.000339	0.00114	CcSEcCtD
Phentermine—Nausea—Triamcinolone—psoriasis	0.000337	0.00113	CcSEcCtD
Phentermine—Dyspepsia—Methotrexate—psoriasis	0.00033	0.00111	CcSEcCtD
Phentermine—Vomiting—Betamethasone—psoriasis	0.000327	0.0011	CcSEcCtD
Phentermine—Vomiting—Dexamethasone—psoriasis	0.000327	0.0011	CcSEcCtD
Phentermine—Rash—Betamethasone—psoriasis	0.000324	0.00109	CcSEcCtD
Phentermine—Rash—Dexamethasone—psoriasis	0.000324	0.00109	CcSEcCtD
Phentermine—Dermatitis—Dexamethasone—psoriasis	0.000324	0.00109	CcSEcCtD
Phentermine—Dermatitis—Betamethasone—psoriasis	0.000324	0.00109	CcSEcCtD
Phentermine—Gastrointestinal disorder—Methotrexate—psoriasis	0.000323	0.00109	CcSEcCtD
Phentermine—Fatigue—Methotrexate—psoriasis	0.000323	0.00108	CcSEcCtD
Phentermine—Headache—Betamethasone—psoriasis	0.000322	0.00108	CcSEcCtD
Phentermine—Headache—Dexamethasone—psoriasis	0.000322	0.00108	CcSEcCtD
Phentermine—Asthenia—Prednisone—psoriasis	0.000322	0.00108	CcSEcCtD
Phentermine—CYP1A2—Xenobiotics—CYP2S1—psoriasis	0.000319	0.0337	CbGpPWpGaD
Phentermine—Diarrhoea—Prednisone—psoriasis	0.000307	0.00103	CcSEcCtD
Phentermine—Nausea—Dexamethasone—psoriasis	0.000306	0.00103	CcSEcCtD
Phentermine—Nausea—Betamethasone—psoriasis	0.000306	0.00103	CcSEcCtD
Phentermine—Urticaria—Methotrexate—psoriasis	0.000298	0.000998	CcSEcCtD
Phentermine—Dizziness—Prednisone—psoriasis	0.000296	0.000994	CcSEcCtD
Phentermine—Abdominal pain—Methotrexate—psoriasis	0.000296	0.000994	CcSEcCtD
Phentermine—MAOA—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000291	0.0307	CbGpPWpGaD
Phentermine—Vomiting—Prednisone—psoriasis	0.000285	0.000956	CcSEcCtD
Phentermine—Rash—Prednisone—psoriasis	0.000283	0.000948	CcSEcCtD
Phentermine—Dermatitis—Prednisone—psoriasis	0.000282	0.000947	CcSEcCtD
Phentermine—Headache—Prednisone—psoriasis	0.000281	0.000942	CcSEcCtD
Phentermine—Asthenia—Methotrexate—psoriasis	0.000269	0.000902	CcSEcCtD
Phentermine—Nausea—Prednisone—psoriasis	0.000266	0.000893	CcSEcCtD
Phentermine—Diarrhoea—Methotrexate—psoriasis	0.000256	0.00086	CcSEcCtD
Phentermine—Dizziness—Methotrexate—psoriasis	0.000248	0.000831	CcSEcCtD
Phentermine—MAOB—Biological oxidations—CYP2S1—psoriasis	0.000246	0.026	CbGpPWpGaD
Phentermine—Vomiting—Methotrexate—psoriasis	0.000238	0.000799	CcSEcCtD
Phentermine—Rash—Methotrexate—psoriasis	0.000236	0.000792	CcSEcCtD
Phentermine—Dermatitis—Methotrexate—psoriasis	0.000236	0.000792	CcSEcCtD
Phentermine—Headache—Methotrexate—psoriasis	0.000235	0.000787	CcSEcCtD
Phentermine—Nausea—Methotrexate—psoriasis	0.000222	0.000747	CcSEcCtD
Phentermine—MAOB—Tryptophan metabolism—CAT—psoriasis	0.000212	0.0224	CbGpPWpGaD
Phentermine—MAOA—Oxidative Stress—CAT—psoriasis	0.000188	0.0198	CbGpPWpGaD
Phentermine—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000156	0.0165	CbGpPWpGaD
Phentermine—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000155	0.0164	CbGpPWpGaD
Phentermine—MAOA—Biological oxidations—CYP2S1—psoriasis	0.000155	0.0163	CbGpPWpGaD
Phentermine—CYP2D6—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000154	0.0163	CbGpPWpGaD
Phentermine—CYP2C9—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000153	0.0161	CbGpPWpGaD
Phentermine—MAOA—Melatonin metabolism and effects—APOE—psoriasis	0.00015	0.0158	CbGpPWpGaD
Phentermine—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2S1—psoriasis	0.000132	0.014	CbGpPWpGaD
Phentermine—SLC6A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000131	0.0139	CbGpPWpGaD
Phentermine—CYP1A2—Oxidation by Cytochrome P450—CYP2S1—psoriasis	0.000131	0.0138	CbGpPWpGaD
Phentermine—CYP2D6—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000127	0.0134	CbGpPWpGaD
Phentermine—CYP2C9—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000126	0.0133	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—RUNX3—psoriasis	0.000117	0.0124	CbGpPWpGaD
Phentermine—SLC6A3—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—CP—psoriasis	0.000116	0.0123	CbGpPWpGaD
Phentermine—CYP1A2—Phase 1 - Functionalization of compounds—CYP2S1—psoriasis	0.000107	0.0113	CbGpPWpGaD
Phentermine—SLC6A4—NRF2 pathway—TGFA—psoriasis	0.000105	0.0111	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—RUNX3—psoriasis	9.6e-05	0.0101	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—IL13—psoriasis	9.24e-05	0.00976	CbGpPWpGaD
Phentermine—SLC6A2—NRF2 pathway—TGFA—psoriasis	9.03e-05	0.00953	CbGpPWpGaD
Phentermine—MAOA—Melatonin metabolism and effects—NFKB1—psoriasis	8.91e-05	0.00941	CbGpPWpGaD
Phentermine—MAOA—Oxidative Stress—NFKB1—psoriasis	8.67e-05	0.00916	CbGpPWpGaD
Phentermine—SLC6A3—NRF2 pathway—TGFA—psoriasis	8e-05	0.00845	CbGpPWpGaD
Phentermine—SLC6A4—Monoamine Transport—TNF—psoriasis	7.82e-05	0.00826	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—IL13—psoriasis	7.58e-05	0.008	CbGpPWpGaD
Phentermine—SLC6A3—Dopaminergic Neurogenesis—STAT3—psoriasis	7.24e-05	0.00765	CbGpPWpGaD
Phentermine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	7.11e-05	0.00751	CbGpPWpGaD
Phentermine—CYP2D6—Biological oxidations—CYP2S1—psoriasis	6.73e-05	0.00711	CbGpPWpGaD
Phentermine—SLC6A2—Monoamine Transport—TNF—psoriasis	6.72e-05	0.0071	CbGpPWpGaD
Phentermine—CYP2C9—Biological oxidations—CYP2S1—psoriasis	6.67e-05	0.00704	CbGpPWpGaD
Phentermine—CYP2D6—Metapathway biotransformation—CYP2S1—psoriasis	6.64e-05	0.00701	CbGpPWpGaD
Phentermine—CYP2C9—Metapathway biotransformation—CYP2S1—psoriasis	6.58e-05	0.00695	CbGpPWpGaD
Phentermine—CYP2D6—Melatonin metabolism and effects—APOE—psoriasis	6.52e-05	0.00689	CbGpPWpGaD
Phentermine—CYP1A2—Estrogen Receptor Pathway—JUN—psoriasis	6.49e-05	0.00685	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriasis	6.35e-05	0.00671	CbGpPWpGaD
Phentermine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—psoriasis	6.08e-05	0.00642	CbGpPWpGaD
Phentermine—SLC6A2—SLC-mediated transmembrane transport—CP—psoriasis	5.96e-05	0.0063	CbGpPWpGaD
Phentermine—SLC6A3—Monoamine Transport—TNF—psoriasis	5.95e-05	0.00629	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—IL10—psoriasis	5.78e-05	0.00611	CbGpPWpGaD
Phentermine—CYP1A2—Biological oxidations—CYP2S1—psoriasis	5.7e-05	0.00602	CbGpPWpGaD
Phentermine—CYP1A2—Metapathway biotransformation—CYP2S1—psoriasis	5.62e-05	0.00594	CbGpPWpGaD
Phentermine—CYP1A2—Estrogen Receptor Pathway—STAT3—psoriasis	5.61e-05	0.00593	CbGpPWpGaD
Phentermine—CYP1A2—Melatonin metabolism and effects—APOE—psoriasis	5.53e-05	0.00584	CbGpPWpGaD
Phentermine—SLC6A3—SLC-mediated transmembrane transport—CP—psoriasis	5.28e-05	0.00558	CbGpPWpGaD
Phentermine—CYP2C9—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.96e-05	0.00524	CbGpPWpGaD
Phentermine—MAOB—Metabolism—NDUFA5—psoriasis	4.95e-05	0.00523	CbGpPWpGaD
Phentermine—CYP1A2—Tryptophan metabolism—CAT—psoriasis	4.92e-05	0.00519	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—IL10—psoriasis	4.74e-05	0.00501	CbGpPWpGaD
Phentermine—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—psoriasis	4.24e-05	0.00448	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CYP2S1—psoriasis	4.21e-05	0.00445	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—LEP—psoriasis	3.88e-05	0.0041	CbGpPWpGaD
Phentermine—CYP2D6—Melatonin metabolism and effects—NFKB1—psoriasis	3.88e-05	0.0041	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—NOS2—psoriasis	3.62e-05	0.00382	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—PPARG—psoriasis	3.38e-05	0.00357	CbGpPWpGaD
Phentermine—CYP1A2—Melatonin metabolism and effects—NFKB1—psoriasis	3.29e-05	0.00347	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—CXCL8—psoriasis	3.16e-05	0.00334	CbGpPWpGaD
Phentermine—MAOA—Metabolism—NDUFA5—psoriasis	3.11e-05	0.00328	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—CP—psoriasis	3.03e-05	0.0032	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—JUN—psoriasis	2.94e-05	0.0031	CbGpPWpGaD
Phentermine—SLC6A2—Transmembrane transport of small molecules—CARM1—psoriasis	2.89e-05	0.00305	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—NFKB1—psoriasis	2.83e-05	0.00299	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—psoriasis	2.73e-05	0.00288	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—CP—psoriasis	2.68e-05	0.00284	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CYP2S1—psoriasis	2.64e-05	0.00279	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—CXCL8—psoriasis	2.59e-05	0.00274	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—VEGFA—psoriasis	2.57e-05	0.00271	CbGpPWpGaD
Phentermine—SLC6A3—Transmembrane transport of small molecules—CARM1—psoriasis	2.56e-05	0.0027	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—JUN—psoriasis	2.41e-05	0.00254	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—JUN—psoriasis	2.4e-05	0.00253	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—psoriasis	2.36e-05	0.00249	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—NFKB1—psoriasis	2.32e-05	0.00245	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—NFKB1—psoriasis	2.27e-05	0.0024	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—TNF—psoriasis	2.2e-05	0.00232	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—VEGFA—psoriasis	2.1e-05	0.00222	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—psoriasis	2.06e-05	0.00218	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CARM1—psoriasis	2.06e-05	0.00217	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—TNF—psoriasis	1.8e-05	0.00191	CbGpPWpGaD
Phentermine—SLC6A4—SIDS Susceptibility Pathways—IL6—psoriasis	1.78e-05	0.00188	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriasis	1.77e-05	0.00187	CbGpPWpGaD
Phentermine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriasis	1.77e-05	0.00187	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—TP53—psoriasis	1.58e-05	0.00167	CbGpPWpGaD
Phentermine—MAOA—SIDS Susceptibility Pathways—IL6—psoriasis	1.46e-05	0.00154	CbGpPWpGaD
Phentermine—SLC6A4—Circadian rythm related genes—IL6—psoriasis	1.45e-05	0.00153	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—NDUFA5—psoriasis	1.35e-05	0.00143	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—NDUFA5—psoriasis	1.34e-05	0.00142	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CARM1—psoriasis	1.29e-05	0.00136	CbGpPWpGaD
Phentermine—MAOB—Metabolism—CAT—psoriasis	1.27e-05	0.00134	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.25e-05	0.00132	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CYP2S1—psoriasis	1.15e-05	0.00122	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—NDUFA5—psoriasis	1.15e-05	0.00121	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CYP2S1—psoriasis	1.14e-05	0.0012	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—CARM1—psoriasis	1.07e-05	0.00113	CbGpPWpGaD
Phentermine—MAOB—Metabolism—APOE—psoriasis	9.83e-06	0.00104	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CYP2S1—psoriasis	9.75e-06	0.00103	CbGpPWpGaD
Phentermine—MAOB—Metabolism—PPARG—psoriasis	8.56e-06	0.000904	CbGpPWpGaD
Phentermine—MAOA—Metabolism—CAT—psoriasis	7.94e-06	0.000838	CbGpPWpGaD
Phentermine—MAOA—Metabolism—APOE—psoriasis	6.17e-06	0.000651	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.98e-06	0.000631	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CARM1—psoriasis	5.62e-06	0.000593	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CARM1—psoriasis	5.57e-06	0.000588	CbGpPWpGaD
Phentermine—MAOA—Metabolism—PPARG—psoriasis	5.37e-06	0.000567	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—psoriasis	5.21e-06	0.00055	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—psoriasis	5.11e-06	0.000539	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CARM1—psoriasis	4.76e-06	0.000503	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—psoriasis	4.45e-06	0.00047	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—CAT—psoriasis	3.46e-06	0.000365	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—CAT—psoriasis	3.43e-06	0.000362	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—CAT—psoriasis	2.93e-06	0.000309	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—APOE—psoriasis	2.69e-06	0.000284	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—APOE—psoriasis	2.66e-06	0.000281	CbGpPWpGaD
Phentermine—CYP2D6—Metabolism—PPARG—psoriasis	2.34e-06	0.000247	CbGpPWpGaD
Phentermine—CYP2C9—Metabolism—PPARG—psoriasis	2.32e-06	0.000245	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—APOE—psoriasis	2.27e-06	0.00024	CbGpPWpGaD
Phentermine—CYP1A2—Metabolism—PPARG—psoriasis	1.98e-06	0.000209	CbGpPWpGaD
